PubMed=4056357; DOI=10.1016/S0168-8278(85)80002-7
Knuth A., Gabbert H.E., Dippold W.G., Klein O., Sachsse W., Bitter-Suermann D., Prellwitz W., Meyer zum Buschenfelde K.-H.
Biliary adenocarcinoma. Characterisation of three new human tumor cell lines.
J. Hepatol. 1:579-596(1985)

PubMed=21533411; DOI=10.3892/ijo.10.3.545
Moon Y., Dahlberg W.K., Yu Y.-J., Ohno T., Todoroki T., Little J.B.
Radiosensitivity of human biliary tract cancer cell lines in vitro.
Int. J. Oncol. 10:545-551(1997)

PubMed=9824643; DOI=10.3892/ijo.13.6.1269
Koike N., Todoroki T., Kawamoto T., Yoshida S., Kashiwagi H., Fukao K., Ohno T., Watanabe T.
The invasion potentials of human biliary tract carcinoma cell lines: correlation between invasiveness and morphologic characteristics.
Int. J. Oncol. 13:1269-1274(1998)

CLPUB00275
Zach S., Birgin E., Ruckert F.
Primary cholangiocellular carcinoma cell lines.
J. Stem Cell Res. Transplant. 2:1013-1013(2015)

PubMed=26486326; DOI=10.1007/s13277-015-4215-3
Cavalloni G., Peraldo-Neia C., Varamo C., Casorzo L., Dell'Aglio C., Bernabei P., Chiorino G., Aglietta M., Leone F.
Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient.
Tumor Biol. 37:4041-4052(2016)

PubMed=26956050; DOI=10.18632/oncotarget.7914
Ding X.-W., Chaiteerakij R., Moser C.D., Shaleh H.M., Boakye J., Chen G., Ndzengue A., Li Y., Zhou Y.-L., Huang S.-B., Sinicrope F.A., Zou X.-P., Thomas M.B., Smith C.D., Roberts L.R.
Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells.
Oncotarget 7:20080-20092(2016)

PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007
Isidan A., Yenigun A., Soma D., Aksu E., Lopez K., Park Y., Cross-Najafi A., Li P., Kundu D., House M.G., Chakraborty S., Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G.D., Ekser B.
Development and characterization of human primary cholangiocarcinoma cell lines.
Am. J. Pathol. 192:1200-1217(2022)